Efficacy and Safety of Losmapimod in Treating Subjects With Facioscapulohumeral Muscular Dystrophy (FSHD) With Open-Label Extension (OLE)
Condition: Facioscapulohumeral Muscular Dystrophy (FSHD) Intervention: Drug: Losmapimod Sponsor: Fulcrum Therapeutics Enrolling by invitation
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials